• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Photo of Jeremy Kahn
Twitter iconLinkedIn icon
Photo of Jeremy Kahn

Jeremy Kahn

Twitter iconLinkedIn icon

Jeremy Kahn is Fortune's AI Editor, spearheading the publication's coverage of artificial intelligence. He is the author of Mastering AI: A Survival Guide to Our Superpowered Future (Simon & Schuster, July 2024); the lead author of Fortune's Eye on AI newsletter; and a cohost of the Fortune AI Weekly vodcast alongside tech reporter Bea Nolan. Before rejoining Fortune in 2019, he spent eight years at Bloomberg as a technology reporter and a senior writer for Bloomberg Markets magazine. His writing has also appeared in numerous publications including The New York Times, The International Herald Tribune, Newsweek, The Atlantic, Smithsonian, The Boston Globe, and Portfolio. From 2007 to 2011, he reported from New Delhi, India. Prior to moving to India, he was the managing editor of the New Republic. He began his career at Fortune in New York, where he worked from 1997 to 2004. He holds degrees from the University of Pennsylvania and the London School of Economics. He is currently based in London.

An employee assists kids with building a video game using code on an Apple Inc. iPad Mini during the Hour of Code workshop at an Apple store in New York
Newsletters
Learning to code will not save your kids
By Jeremy KahnFebruary 8, 2022
Meta threatens to pull the plug on Facebook and Instagram in Europe over data privacy dispute
Tech
Meta threatens to pull the plug on Facebook and Instagram in Europe over data privacy dispute
By Christiaan Hetzner and Jeremy KahnFebruary 7, 2022
Photo of Elon Musk
Tech
Elon Musk’s brain-implant startup Neuralink may have misled regulators about Musk’s leadership role
By Jeremy KahnFebruary 4, 2022
Neuralink’s leader suddenly departed last year. Employees say his relationship with founder Elon Musk had long felt strained
Tech
Neuralink’s leader suddenly departed last year. Employees say his relationship with founder Elon Musk had long felt strained
By Jeremy Kahn and Jonathan VanianJanuary 31, 2022
Neuralink former employees say Elon Musk applies relentless pressure and instills a culture of blame
Tech
Neuralink former employees say Elon Musk applies relentless pressure and instills a culture of blame
By Jeremy Kahn and Jonathan VanianJanuary 29, 2022
Photo of OpenAI CEO Sam Altman
Newsletters
OpenAI says its making progress on “The Alignment Problem”
By Jeremy KahnJanuary 27, 2022
Inside Neuralink, Elon Musk’s mysterious brain chip startup: A culture of blame, impossible deadlines, and a missing CEO
Magazine
Inside Neuralink, Elon Musk’s mysterious brain chip startup: A culture of blame, impossible deadlines, and a missing CEO
By Jeremy Kahn and Jonathan VanianJanuary 27, 2022
Photo of Julie Sweet
Tech
CEOs of America’s biggest companies detail how to achieve ‘responsible A.I.’
By Jeremy KahnJanuary 26, 2022
Bristol-Myers Squibb logo on a smartphone
Newsletters
What a Bristol-Myers project to monitor off-label prescribing says about future uses of A.I.
By Jeremy Kahn and Jonathan VanianJanuary 25, 2022
Structural images of the main COVID-19 virus variants from Alpha to Omicron.
Health
BioNTech and London A.I. firm create ‘early warning system’ to spot dangerous new COVID-19 variants before they spread
By Jeremy KahnJanuary 12, 2022
Photo of gloves being inspected by human workers at a rubber glove manufacturing plant in China.
Newsletters
At Google Cloud, A.I. ethics requires ‘Iced Tea’ and ‘Lemonaid’
By Jeremy KahnJanuary 11, 2022
Gloved hand holding pills in front of Sanofi corporate logo
Health
Sanofi agrees to partnership with A.I.-based drug discovery company Exscientia worth up to $5.2 billion
By Jeremy KahnJanuary 7, 2022
Photo of Dr. Mike Ryan, WHO health emergencies program director.
Health
WHO to world: Don’t be so confident that Omicron is less dangerous
By Jeremy KahnDecember 30, 2021
Photo illustration of a syringe jabbing a stock chart that shows shares rising and then falling
Finance
Omicron is upping booster jab demand. So why are COVID vaccine makers’ shares tanking?
By Jeremy KahnDecember 29, 2021
Sign saying that customers must wear masks when not seated at the table at a restaurant in Wales
Health
Is Omicron the beginning of the end-emic? Some countries ease COVID restrictions even as infections surge
By Jeremy KahnDecember 28, 2021
1...
  • 25
  • 26
  • 27
  • 28
  • 29
...48
Most Popular
Success
Philanthropy leader at Warren Buffett and Bill Gates’ Giving Pledge says children of billionaires are pushing them to give their wealth away fasterplaceholder alt text
By Preston ForeSeptember 20, 2026
Success
Meet a 71-year-old who retired as a radiologist and professor, and now runs a banana-skewer business: ‘I never want to retire. Why would you do that?’placeholder alt text
By Preston ForeSeptember 20, 2026
Middle East
China suffers another setback in effort to de-dollarize global finance as anchor in the greenback's dominance quietly exits Beijing's payment schemeplaceholder alt text
By Jason MaSeptember 21, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

    © 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.